The magazine for professional developers of consumer packaged goods
Updated on 25/11/2003
Home
Subscribe
Media pack (pdf)
Terms & conditions
Privacy statement
Contact us
Copyright © Gateway Publishing Ltd 2002-2005. All rights reserved.
STOP PRESS

Cookie cutter cuts trans fats

US-based Voortman Cookies plans to eliminate trans fats in all its products by stopping its use of hydrogenated oil.

Voortman vice president Adrian Voortman said the firm will achieve this early next year. The move follows nearly a year of intensive product development and testing to keep the taste of its cookies without hydrogenated oils.

When hydrogen is added to unsaturated fatty acids it creates a fat with a longer shelf life and a higher melting point. Some research has linked these trans fats to a higher risk of heart disease because they raise “bad” LDL cholesterol levels and lower “good” HDL cholesterol levels in your body.

HEADLINE NEWS 25 November 2003

Lies, damn lies and statistics
The cost of corporate rot
Kahlua, Courvoisier pick kosher partner
Congress OKs $3.7bn nanotech bill
Soy equals statins for heart effects

GM

Lies, damn lies and statistics

Bias and selectivity by both advocates and opponents have clouded the results of farm-scale trials of genetically modified crops in Britain, says the president of the Royal Society, Lord May.

Lord May was speaking before a meeting of the Advisory Committee on Releases to the Environment (ACRE) about the implications of the research. The results were published in October. They showed there are pros and cons to GM crops.

"To declare all GM is bad or all GM is good for the environment as a result of these experiments is a gross over-simplification,” Lord May said. “Rather than closing the case for or against GM crops, these results should drive society to ask more questions, not just about GM crops, but about agriculture generally. They should be a catalyst for a debate about the future of modern agriculture."

ACRE is taking evidence in public from experts and stakeholders about this. "The UK has already experienced a pronounced loss of biodiversity,” he said. “If this trend is to be halted, we need to decide now best to achieve that. It could be through working with the grain of nature, such as targeting land for non-agricultural purposes, or by growing our food more efficiently, such as using techniques like GM to develop crops that need fewer chemicals.”

Society has to choose what social and environmental conditions it wants to live in, he said. Then techniques such as GM could be applied to achieve it.

Corruption

The cost of corporate rot

No only is corporate corruption widespread, but it is far more costly to society than street crime, says University of Arkansas researcher Vikas Anand.

Anand and Blake Ashforth from Arizona State University have uncovered three mutually reinforcing processes that undermine corporate ethics: institutionalisation, rationalisation and socialisation. Their results will appear in the 2004 edition of Research in Organizational Behavior.

“In most instances, the behaviour creeps up on people. They are not intentionally evil and they don’t normally start out to be corrupt, but these processes take over and make their behaviour seem normal within their group,” says Anand.

The complexity of many routine business processes allows an initial corrupt decision or act to become embedded in the processes to the point that it becomes routine. For example,

someone at a national pharmacy discovered that Medicare denied 10% of all claims due to errors by Medicare, but Medicare did not correct them errors and the pharmacy lost the money. A pharmacy official decided that, rather than fight with Medicare or take the loss, they could simply duplicate every tenth claim. Because the work is divided among employees, no one person realises what is happening. The data entry operator, for example, has no idea why she was instructed to duplicate every tenth entry; it is just how the job is done. The fraud becomes institutionalised.

Next, ritual stories “explain” such acts and outcomes and make them seem to conform to social norms, eg fairness. For example, the pharmacy official argued that they were not taking any more money than was due to them – they were just being “creative” in circumventing the bureaucratic problems at Medicare and ensuring that their stockholders were not penalised by other agencies’ bookkeeping errors.

“Rationalizations are patently self-serving attempts to legitimate questionable acts,” said Anand, “but because they are for internal consumption, the issue is not their objective validity, but whether the group accepts them.”

This acceptance depends on the socialising power of the organisation and their previous experience of corruption by those who join the organisation. Without them, the corruption would die out when the instigators left the firm.

“There is a strong pretend quality to these normalising techniques,” Anand said. “Peers act as if theft, illegal dumping, false advertising and so on are permissible, if not desirable. Because the goal is to change the attitude toward specific behaviours that would otherwise be repugnant, the group may overlay positive attributes, praising the newcomer by calling the newly-learned corrupt behaviours ‘aggressive,’ ‘with-it’ or ‘loyal’.”

Newcomers who do not respond to social influence threaten the corrupt subculture. They will be told in different ways to fit in or leave – it’s my way or the highway.

All three processes must be present for corruption to become an ongoing, collective undertaking. So prevention is better than cure.

Ashcroft and Anand believe that leaders should instil high ethical values and awareness and hold individuals at all levels accountable for the means as well as the ends. “Organisations tend to get the respect they deserve,” say Ashcroft and Anand. For instance, electronic surveillance of staff may communicate distrust and provoke retaliation through corruption.

Remedial actions should not be aimed at managing the corporate image, said Anand. “Unfortunately, some executives design ethics codes to stop staff acting against the company rather than to control corrupt activities on behalf of the company.”

Brands

Kahlua, Courvoisier pick kosher partner

Expect Kahlua- and Courvoisier-branded sauces and flavoured beverage concentrates to emerge from a licensing deal between Allied Domecq’s North America spirits division and kosher specialist Vita Food Products.

Vita Foods' plans to make Kahlua dessert sauces, Kahlua cappuccino concentrate, Courvoisier Dill Dijon Mustard sauce and Courvoisier cappuccino concentrate.

Buyer presentations will begin in December with a planned launch to consumers scheduled for January 2004.

Allied Domecq’s vice president for new business innovation, David Hayes, said "Our partnership with Vita Food Products for these new Kahlua- and Courvoisier-branded products marks another important step forward in Allied Domecq's brand extension programme." Other licensing deals include Sauza, Kahlua and Malibu non-alcoholic cocktail mixers from American Beverage Corporation in the US, and Sara Lee Kahlua ice cream in Australia.

Vita Foods supplies the herring and retail packaged salmon markets in the US, as well as cream cheese, cocktail sauce, tartar sauce and horseradish. More than 95% of Vita's sales are in kosher foods.

Materials

Congress OKs $3.7bn nanotech bill

While the UK and Europe worry about the ethics of nanotechnology, the US is to spend nearly $3.7bn over four years from October 2004 on nanotechnology research and development

A bill passed by Congress sets up a White House National Nanotechnology Program office and a network of university-based advanced technology centres. They will include medical ethics, legal, and environmental issues.

Sherwood Boehlert, chairman of the House Science Committee and one of the bill's sponsors, said “The capability will have enormous consequences for the information industry, for manufacturing, and for medicine and health.”

Diet

Soy equals statins for heart effects

Soy foods appear as effective in lowering cholesterol as statin drugs, according to reports from the University of California at Berkeley and also from Cornell University.

Research into the Portfolio diet, which features soy foods, such as tofu and soy milk, found that the diet "worked as well as the drug and much better than the low-fat diet, reducing total cholesterol by about one-third in only a few weeks," Berkeley sources say.

In a Cornell study, 46 men and women with high cholesterol were assigned to a vegetarian diet containing soy protein. Test patients on the diet with soy protein had an average decrease of 28.6% in their LDL (“bad”) cholesterol, about equal to the loss for a group receiving a statin drug. Those on a traditional low-fat diet saw a decrease of only 8%.

 
Tuesday, 01 February 2005
Events
FishWrap
NumbersGames
PaperChase
Library
Links